Hyam Levitsky
Overview
Hyam Levitsky received an average of $8M in total compensation, including $314K in salary, at Juno Therapeutics between 2015 and 2016.
Source: SEC filing on April 21, 2017.
Related executives
We found five more executives who work or worked at Juno Therapeutics.
Hans Bishop
Juno Therapeutics
Chief Executive Officer
Steven Harr
Juno Therapeutics
Chief Financial Officer
Robert Azelby
Juno Therapeutics
Executive Vice President, Chief Commercial Officer
Bernard Cassidy
Juno Therapeutics
General Counsel
Mark Frohlich
Juno Therapeutics